Answer
If an adverse reaction occurs during administration of Hepatect CP human hepatitis B immunoglobulin, the infusion rate must be reduced or the infusion stopped.
Sources for this answer
- Hepatect CPGrifols UK Ltd · emc · SmPC §4.2 Posology and method of administration · Version 9Document updated
Sources checked